跳至主要内容
临床试验/ACTRN12610000382077
ACTRN12610000382077已完成未知

In preterm infants born less than 33 weeks gestation will a tuna oil emulsion containing 121 mg/ml or 76 mg/ml of docosahexaenoic acid (DHA) compared with 37 mg/ml of DHA achieve an erythrocyte phospholipid fatty acid profile comparable to a term infant profile?

Women's and Children's Health Research Institute0 个研究点目标入组 30 人开始时间: 2010年5月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
2 Days 至 14 Days(—)
性别
All

入选标准

  • Infants born less than 33 weeks gestation after one but before five days of commencing any enteral feeds and with parental/guardian consent. Multiple births will be eligible and will be randomised individually. Women providing breast milk for their infant not taking DHA supplements or willing to stop taking supplements for duration study.

排除标准

  • Infants with major congenital or chromosomal abnormalities. Infants likely to be transferred to remote locations where weekly blood tests can’t be done.

研究者

发起方
Women's and Children's Health Research Institute

相似试验

Determining the docosahexaenoic acid dose to obtain... | 临床试验